Table 1.
Characteristics of Patients
| Patient Characteristic | Entire Cohort N=798,217 |
Inpatient Stay Cohort N=73,137 |
New Start Cohort N=421,536 |
|---|---|---|---|
| Gender | |||
| Female | 59,080 (7.4) | 3,831 (5.2) | 33,155 (7.9) |
| Male | 739,137 (92.6) | 69,306 (94.8) | 388,381 (92.1) |
| Race | |||
| African American | 108,612 (13.6) | 18,178 (24.9) | 55,614 (13.2) |
| White | 671,008 (84.1) | 53,094 (72.6) | 356,031 (84.5) |
| Other | 18,597 (2.3) | 1,865 (2.6) | 9,891 (2.4) |
| Hispanic | |||
| No | 759,663 (95.2) | 69,393 (94.9) | 399,815 (94.9) |
| Yes | 38,554 (4.8) | 3,744 (5.1) | 21,721 (5.2) |
| Age | |||
| 18-44 years old | 114,073 (14.3) | 19,161 (26.2) | 63,093 (15.0) |
| 45-64 years old | 387,218 (48.5) | 42,960 (58.7) | 199,515 (47.3) |
| >=65 years old | 296,926 (37.2) | 11,016 (15.1) | 158,928 (37.7) |
| Marital Status | |||
| Married | 437,768 (54.8) | 25,999 (35.5) | 233,945 (55.5) |
| Not Married | 356,885 (44.7) | 47,025 (64.3) | 185,801 (44.1) |
| Any substance abuse* | |||
| No | 620,569 (77.7) | 24,841 (34.0) | 335,435 (79.6) |
| Yes | 177,648 (22.3) | 48,296 (66.0) | 86,101 (20.4) |
| Comorbid Psychiatric Diagnosis† | |||
| No | 451,906 (56.6) | 29,923 (40.9) | 249,046 (59.1) |
| Yes | 346,312 (43.4) | 43,214 (59.1) | 172,490 (40.9) |
| Charlson Medical Comorbidity | |||
| 0 | 476,676 (59.7) | 47,468 (64.9) | 268,731 (63.8) |
| >=1 | 321,541 (40.3) | 25,669 (35.1) | 152,805 (36.3) |
| Region (location on entry into cohort) | |||
| North East | 161,781 (20.3) | 15,793 (21.6) | 81,768 (19.4) |
| Central | 179,746 (22.5) | 17,852 (24.4) | 94,601 (22.4) |
| South | 302,843 (37.9) | 25,257 (34.5) | 164,382 (39.0) |
| West | 153,847 (19.3) | 14,235 (19.5) | 80,785 (19.2) |
Cell values are N (%).
*
Diagnosis of alcohol or other substance abuse 12 months prior to entry through end of study period
†
Diagnosis of PTSD, Personality Disorder or Other Anxiety Disorder 12 months prior to entry through end of study period